Culprit Mechanism(s) for Exercise Intolerance in Heart Failure With Normal Ejection Fraction.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed.

1. Understanding heterogeneous mechanisms of heart failure with preserved ejection fraction through cardiorenal mathematical modeling.PLoS computational biology · 2023
   Article
2. Epigenetic remodeling in heart failure with preserved ejection fraction.Current opinion in cardiology · 2022
   Review
3. Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies.European heart journal · 2021
   Review
4. Transitioning from Preclinical to Clinical Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach.Journal of clinical medicine · 2020
   Review
5. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.Circulation · 2016
   Review
6. [Exercise training as a key component of heart failure therapy].Herz · 2015
   Article
7. Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to left heart disease.Annals of thoracic medicine · 2014
   Article
8. [Exercise training in heart failure].Der Internist · 2014
   Article
9. Developing therapies for heart failure with preserved ejection fraction: current state and future directions.JACC. Heart failure · 2014
   Review
10. [Exercise training in heart failure].Herz · 2013
    Article
11. WHO's in second?: A practical review of World Health Organization group 2 pulmonary hypertension.Chest · 2013
    Review
12. Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction.European journal of heart failure · 2013
    Article
13. Right and left ventricular diastolic pressure-volume relations: a comprehensive review.Journal of cardiovascular translational research · 2013
    Review
14. Exercise tolerance in asymptomatic patients with moderate-severe valvular heart disease and preserved ejection fraction.Archives of medical science : AMS · 2012
    Article
15. Molecular and cellular basis for diastolic dysfunction.Current heart failure reports · 2012
    Review
16. Integration target site selection for retroviruses and transposable elements.Cellular and molecular life sciences : CMLS · 2004
    Review

Corrections and comments

• Comment on
  Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction.2010
• Comment on
  Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction.2010

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as